TrialBreast cancer (Dove Medical Press)2024

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.